
==== Front
Heliyon
Heliyon
Heliyon
2405-8440
Elsevier

S2405-8440(24)13112-X
10.1016/j.heliyon.2024.e37081
e37081
Research Article
The effects of resistance training on cardiovascular factors and anti-inflammation in diabetic rats
Yoo Jin a
Hwang Jinsu b
Choi Jiyun b
Ramalingam Mahesh b
Jeong Haewon c
Jang Sujeong bc1
Jeong Han-Seong bc1
Kim Daeyeol kimdaeyeol@jnu.ac.kr
a⁎
a Department of Physical Education, Chonnam National University, Gwangju, 61186, Republic of Korea
b Department of Physiology, Chonnam National University Medical School, Hwasun-gun, Jeollanamdo, 58128, Republic of Korea
c StemCell Bio Incorporated, Hwasun-gun, Jeollanamdo, 58128, Republic of Korea
⁎ Corresponding author. kimdaeyeol@jnu.ac.kr
1 Co-correspondenceSujeong Jang, Han-Seong Jeong.

28 8 2024
15 9 2024
28 8 2024
10 17 e3708123 6 2024
25 8 2024
27 8 2024
© 2024 The Authors
2024
https://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Diabetes induces a range of macrovascular and microvascular changes, which lead to significant clinical complications. Although many studies have tried to solve the diabetic problem using drugs, it remains unclear. In this study, we investigated whether resistance exercise affects cardiovascular factors and inflammatory markers in diabetes. The study subjected Otsuka Long-Evans Tokushima Fatty (OLETF) rats, which have genetically induced diabetes mellitus, to a resistance exercise program for 12 weeks and assessed the levels of cardiovascular factors and inflammatory markers using western blotting analysis, ELISA, and immunohistochemistry. During the training period, OLETF + exercise (EX) group exhibited lower body weight and reduced glucose levels when compared with OLETF group. Western blotting analysis, ELISA, and immunohistochemistry revealed that the levels of PAI-1, VACM-1, ICAM-1, E-selectin, TGF-β, CRP, IL-6, and TNF-α were decreased in OLETF + EX group when compared with the OLETF group. Moreover, the anti-inflammatory markers, IL-4 and IL-10, were highly expressed after exercise. Therefore, these results indicate that exercise may influence the regulation of cardiovascular factors and inflammatory markers, as well as help patients with metabolic syndromes regulate inflammation and cardiovascular function.

Highlights

• Resistance training reduces blood glucose levels.

• Exercise lowers the levels of cardiovascular factors.

• Exercise regulates inflammation.

• Resistance training elevates anti-inflammatory factors.

Keywords

Diabetes
Resistance exercise
Cardiovascular response
Endothelia
Inflammation
==== Body
pmc1 Introduction

Diabetes, a chronic metabolic disease that affects an individual's physical, social, and mental well-being, leads to chronic hyperglycemia because of impaired response to insulin and/or impaired insulin secretion [[1], [2], [3]]. Insulin plays a key role in lowering blood glucose levels by inducing accelerated blood glucose transport into muscle cells and glucose uptake, leading to normal blood glucose levels during hyperglycemic reactions to emergencies or stress [4]. There are two main types of diabetes mellitus, type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) [5]. T1DM is a caused by insulin deficiency after the loss of pancreatic β-cells [[6], [7], [8]], whereas T2DM is characterized by insulin resistance and progressive β-cell dysfunction [9].

Cardiovascular complications are leading causes of death and disability in patients with diabetes [10,11]. When compared with people without diabetes, patients with T2DM have a disproportionately higher rate of cardiovascular diseases (CVD)-associated morbidity and mortality [[11], [12], [13]]. Epigenetic factors, reactive oxygen species, glucolipotoxicity, activation of various transcription-mediated pathways, and increased levels of various pro-inflammatory cytokines, contribute to insulin resistance and the pathogenesis of T2DM [14]. Individuals with metabolic syndrome exhibit simultaneously combined pro- and anti-inflammatory conditions which more probably can lead to cardiovascular diseases progression, T2DM, and some types of cancer, such as pancreatic cancer [15], prostate cancer [16], gastrointestinal stromal tumors [17], and gastric cancer [18,19]. Insulin resistance has been shown to substantially correlate with the plasma levels of plasminogen activator inhibitor 1 (PAI-1) [20], which is an important risk factor for CVD [[21], [22], [23]]. T2DM and CVD may be associated with elevated levels of PAI-1 production and circulation [23,24]. PAI-1 can control the levels of various factors, including growth factors (e.g., transforming growth factors (TGF)-β), hormones (e.g., insulin), inflammatory cytokines (e.g., tumor necrosis factor (TNF)-α and interleukin (IL)-6), and endotoxins [25,26]. Increased levels of C-reactive protein (CRP), TNF-α, and IL-6 have been observed in diabetes [[27], [28], [29]]. In addition, CRP levels are raised by several pro-inflammatory cytokines, including IL-6 and TNF-α, which increase oxidative stress and decrease eNOS phosphorylation, thereby enhancing endothelial dysfunction in patient with T2DM [30,31].

To help patients with T2DM reach and maintain their therapeutic goals and improve their quality of life, physical activity is essential, along with medication, diet control, bariatric surgery, and exercise [32,33]. Exercise therapy includes aerobic exercise, resistance exercise, high-intensity interval training, and combined exercise [[34], [35]]. Patients with diabetes should undergo moderate- or vigorous-intensity aerobic training for >150 and > 75 min per week, respectively [[36], [37]]. However, for people with severe obesity, arthritis, physical disabilities, or diabetes complications, walking, even for 20–30 min, can be difficult, uncomfortable, or painful [38]. Recent studies show that resistance training may be able to prevent, treat, and even reverse several chronic conditions [39]. It can result in positive muscle mass changes and enhance glucose storage and blood glucose clearance [40]. Furthermore, resistance training may increase bone mineral density, lean body mass, and muscular strength, which may improve glycemic management and prevent osteoporosis and sarcopenia [38]. Previous studies indicate that performing resistance training may efficiently influence middle-aged and older people to reduce insulin sensitivity and prevent T2DM [41,42].

Several studies indicate that resistance exercise may be especially beneficial for people with T2DM because they increase insulin activity [43], while reducing the risk of low-grade inflammatory disorders like atherosclerosis, obesity, and insulin resistance [44]. In addition, exercise suppresses TGF-β production and cellular aging, thereby preventing and delaying CVD [45]. General exercise programs increase the number of smooth muscle and endothelial cells, dilate arterial diameter, and expand aortic vessels [46].

However, few studies have investigated the mechanisms underlying the relationship between cardiovascular factors and anti-inflammation following resistance training. This study investigated the effects of 12-week resistance training on cardiovascular and inflammation responses in a rat model of T2DM. We subjected the rats’ heart sample to western blotting analysis, ELISA, and immunohistochemistry analyses. This study aimed to suggest an enhanced resistance training program for patients with diabetes.

2 Materials and methods

2.1 Animals

Animal experiment protocols were approved by the Institutional Animal Care and Use Committee (CNU IACUC-YB-2020-95) of Chonnam National University, Republic of Korea. Every effort was made to lessen the suffering of the animals. Male Otsuka Long-Evans Tokushima Fatty (OLETF) rats (n = 24), an obese genetic rat model of T2DM, and Long-Evans Tokushima Otsuka (LETO) rats (n = 14), a genetic control group, aged four weeks, were purchased from Central Lab. Animal, Inc. (Seoul, Republic of Korea). Glucose level measurements at 19 weeks of age confirmed that the OLETF group had diabetes. The LETO rats formed the control group, whereas the OLETF rats were randomly assigned to the diabetes group (n = 11) and diabetes with resistance exercise group (OLETF + EX, n = 13). The OLETF + EX group was raised for another 15 weeks, with exercise from the age of 19 weeks, when diabetes was detected. The rats were housed at 24 °C, with a 12-h light/dark cycle and free access to food and water.

2.2 Resistance exercise

The rats underwent resistance exercise three days a week, eight times a day, for 12 weeks on a climbing ladder (length: 110 cm, space between rungs: 1.6 cm, width: 20 cm, inclination: 80°) modified from a previous study [47]. Before resistance exercises, the rats underwent pre-adaptation training three days a week, three times a day, for two weeks without loads. In the first and second weeks after starting resistance training, they underwent exercise without loads for three days a week, five times a day. In weeks three, four, and five, and weeks six to seven, loads equivalent to 50 %, 75 %, 90 %, and 100 % of the rats’ body weights were attached to their tails three days a week, eight times a day. From week eight, the rats underwent gradual resistance exercises with loads equivalent to 50 %, 75 %, 90 %, and 100 % of their body weights, four times and four to eight times, and eventually with an additional 30 g to the respective rat weights. Without loads, the rats were allowed to rest for 1 min between each set of exercises. With weight exercises, they were allowed to rest for 2 min between each set of exercises. The load exercise steps are listed in Table 1.Table 1 Resistance exercise program.

Table 1Weeks	Resistance exercise program	Times/Period	
1–2	Body weight	3 days/week	
3	+50 % of body weight	
4	+75 % of body weight	
5	+90 % of body weight	
6–7	+100 % of body weight	
8–12	incremental load exercise
+50 %, 75 %, 90 %, 100 %, 100 % + 30g of body weight	

2.3 Measurement of body weight and blood glucose

The rats were monitored by measuring their body weights once a week using a weighing scale (FX-2000i, A&D Company, Limited, Tokyo, Japan). Blood glucose levels were monitored weekly after exercise and fasting for 16 h by restraining the rats using rat holders and drawing blood samples from the tail vein. Blood glucose was measured using an ACCU-CHEK glucometer (Active, Roche, Basel, Switzerland).

2.4 Intraperitoneal glucose tolerance test

In this study, we confirmed that the rats had diabetes using an intraperitoneal glucose tolerance test (IPGTT) that was modified from a previous study [48]. Briefly, after 16 h of fasting, we intraperitoneally injected the rats with a glucose solution (2 g/kg). Next, they were restrained in rat holders for tail vein blood collection, followed by blood glucose measurement after 30, 60, and 90 min as described above.

2.5 Tissue preparation

Animals were anesthetized using sodium pentobarbital (75 mg/kg), transcardially perfused with phosphate-buffered saline (PBS, BIOSESANG, Yongin, Republic of Korea) or fixed with fresh paraformaldehyde (PFA, BIOSESANG) in 0.1 M phosphate buffer (pH 7.4, Sigma-Aldrich, Burlington, USA). For western blotting analysis, PBS-perfused hearts were stored at −80 °C. For immunohistochemistry, the hearts were harvested, fixed in PFA for 24 h, and then stored in 30 % sucrose for three days [49].

2.6 Western blotting analysis

Protein concentrations were determined using the BCA Protein Assay Kit (Thermo Scientific, Rockford, IL, USA). Equal protein amounts (15 μg/10 μl) were separated on 7 or 10 % SDS-polyacrylamide (Bio-Rad, Hercules, USA) and then transferred onto polyvinylidene difluoride membranes (Merck Millipore, Burlington, USA). The membranes were then blocked using 5 % skimmed milk (BD, Franklin Lakes, USA) in PBS with 0.1 % Tween-20 (T-PBS) for 60 min and incubated overnight at 4 °C with anti-PAI-1 (1:1000, ab222754, abcam, Cambridge, UK), anti-VCAM-1 (1:1000, ab134047, abcam), anti-ICAM-1 (1:1000, ab171123, abcam), anti-E-selectin (1:1000, sc-137054, Santa Cruz Biotechnology, Inc., Texas, USA), anti-TGF- β (1:1000, ab215715, abcam), anti-CRP (1:1000, ab259862, abcam), anti-TNF-a (1:1000, ab205587, abcam), IL-6 (1:1000, ab9324, abcam), anti-IL-4 (1:1000, sc-53084, Santa Cruz Biotechnology), and anti-IL-10 (1:1000, A2171-100, ABclonal Science, Inc., Hubei, China). The membranes were then washed for 30 min in T-PBS and incubated in an HRP-conjugated secondary antibody (Cell Signaling Technology, Danvers, USA) in a blocking buffer. They were conducted by signal development using the Immobilon Crescendo Western HRP Substrate (Millipore, Burlington, USA). The signals were then imaged on a LAS 4000 system (GE Healthcare, Japan) [50].

2.7 ELISA

The levels of cardiovascular factors and immune reactions were measeured using ELISA kits (Elabscience, Wuhan, China). Following the protocol, 100 μl of tissue lysates were incubated with 100 μl biotinylated detection antibodies against PAI-1, VCAM-1, ICAM-1, E-selection, TGF-β, CRP, TNF-α, IL-6, IL-4, and IL-10, at 37 °C for 90 min. After substrate addition, the protein signal was measured at a wavelength of 450 nm on a microplate reader (BioTek, Winooski, USA) according to the manufacturer's specifications [51].

2.8 Immunohistochemistry

For immunohistochemical analysis, tissues were cryo-sectioned onto slides using a DE/CM1860 cryo-microtome (Leica Biosystems, Nussloch, Germany). They were then incubated with primary antibodies against PAI-1 (1:100, abcam), VCAM-1 (1:400, abcam), ICAM-1 (1:100, abcam), E-selectin (1:500, Santa Cruz Biotechnology), TGF-β (1:500, abcam), CRP (1:2200, abcam), TNF-α (1:100, abcam), IL-6 (1:1000, abcam), IL-4 (1:50, Santa Cruz Biotechnology), and IL-10 (1:500, ABclonal Science, Inc., Woburn, USA) diluted in 10 % normal goat serum (NGS, Vector Laboratories, Newark, USA), at room temperature for 1.5 h. Next, they were incubated with biotinylated anti-rabbit secondary antibody (1:500, Santa Cruz Biotechnology) and the signal was developed using a Vector Elite ABC kit (1:100, Vector Laboratories). The antibody-biotin-avidin-peroxidase complexes were visualized using 0.03 % DAB. The sections were examined under a light microscope equipped with a digital camera and scanning program (ZEISS Axio Vert.A1, Carl Zeiss, Göttingen, Germany) [52].

2.9 Statistical analysis

Statistical analyses were done on GraphPad Prism® 5.0 (GraphPad Software Inc., San Diego, CA, USA). Differences in body weight and blood glucose were compared using a two-way repeated measures ANOVA. P < 0.05 indicates statistically significant differences. If the means of two different groups were statistically significant different, they were analyzed using a post-hoc Bonferroni test. Western blotting analysis, ELISA, and immunohistochemistry data were analyzed using one-way ANOVA and Tukey's post-hoc tests. *, **, and *** indicate p < 0.05, <0.01, and <0.001, respectively.

3 Results

3.1 The effect of resistance exercise on blood glucose levels

We decided to exercise for the study and all the experimental procedure was performed following the schedule, which explained in Fig. 1A. For 14 weeks, the animal had a pre-training and regular exercise for three days/week and was checked the body weight and the level of glucose in the blood. After 12 weeks, tissue was collected for the molecular works such as western blotting analysis, ELISA, and immunohistochemistry. To characterize the development of T2DM in OLETF, we monitored the rats’ blood glucose levels. This analysis showed that fasting insulin levels were significantly higher in OLETF rats when compared with LETO rats. Moreover, blood glucose levels were significantly lower in the OLETF + EX group when compared with the OLETF group at weeks 2, 9, and 12 (Fig. 1B). In addition, the IPGTT method confirmed that glucose levels after 30, 60, and 90 min were continuously sustained in the OLETF group when compared with the LETO group (Fig. 1C).Fig. 1 Experimental procedure and a level of blood glucose and body weight. (A) The experimental procedure was conducted according to the following schedule. Pre-exercise was performed before 2 weeks training. Body weight was measured once at every week. Resistance exercise was held three days per week until 12 weeks. At 12 weeks after exercise, tissue was collected for analysis using western blotting, ELISA, and immunohistochemistry. (B) **p < 0.01, ***p < 0.001 compared to the OLETF group. The level of blood glucose of OLETF group was higher than the OLETF + EX group. (C) To assess diabetes induction, the result of an IPGTT was examined. The IPGTT results showed that the glucose values from 30 to 90 min after glucose loading were significantly lower in the LETO group than in the OLETF group. (D) **p < 0.01, ***p < 0.001, and ***p < 0.001 compared with OLETF. The body weight of OLETF group was increased compared with the OLETF + EX groups until 11 weeks.

Fig. 1

3.2 The effect of resistance exercise on body weight

During the experiment, body weight in the OLETF group was consistently higher than in the LETO group. The OLETF group's body weight increased slightly from the beginning to the end of the experiment. However, the OLETF + EX group did not exhibit a significant difference in the body weight at the start versus the end of the experiments. Five weeks after exercise, the OLETF + EX group had a lower body weight than the OLETF group, which persisted until the end of the exercise (Fig. 1D).

3.3 The effect of exercise on cardiovascular factors and inflammatory markers

We used western blotting analysis to assess the levels of cardiovascular factors and inflammatory markers, including VCAM-1, ICAM-1, TGF-β, CRP, IL-6, IL-4, and IL-10 (Fig. 2 and Fig. S1). This analysis revealed that the exercise group expressed lower levels of the cardiovascular inflammation and pro-inflammatory markers, IL-6 and CRP when compared with the OLETF group (Fig. 2D and E). However, the level of IL-10, an anti-inflammatory marker, was decreased in the OLETF group and increased in the resistance exercise group (Fig. 2G). The levels of the cardiovascular factors did not differ significantly between the OLETF and OLETF + EX groups (Fig. 2A–C). In addition, we did not obtain results from the western blotting analysis of the expression of PAI-1, E-selectin, and TNF-α (data not shown). Furthermore, there were no significant differences in the levels of the anti-inflammatory marker, IL-4. These results indicate that resistance exercise reduces inflammation by regulating pro-inflammatory markers in the rat model of diabetes.Fig. 2 Expression of cardiovascular factors and inflammatory markers. The levels of cardiovascular factors, VACM-1(A) and ICAM-1 (B), fibrotic marker, TGFβ (C), cardiovascular inflammatory marker, CRP (D), pro-inflammatory marker, IL-6 (E), and anti-inflammatory markers, IL-4 (F) and IL-10 (G) were determined via western blotting analysis. GAPDH and β-actin were used as an endogenous control. (H) The protein levels of cardiovascular factors (PAI-1, VACM-1, ICAM-1 and E-selectin), fibrotic marker (TGF-β), cardiovascular inflammatory marker (CRP), pro-inflammatory markers, (TNF-α and IL-6), and anti-inflammatory markers, (IL-4 and IL-10) were determined via ELISA assay. All experiments were repeated at least three times. *p < 0.05, ***p < 0.001 compared with the OLETF group.

Fig. 2

Validation of the western blotting analysis using ELISA revealed lower levels of VCAM-1, ICAM-1, E-selectin, CRP, IL-6, and TNF- α in the OLETF + EX group when compared with the OLETF group (Fig. 2H). Interestingly, the anti-inflammatory markers, IL-4 and IL-10, were highly expressed after exercise. Taken together, these data show that exercise influences the regulation of inflammation by upregulating anti-inflammatory factors and the downregulating cardiovascular factors and pro-inflammatory markers.

3.4 The effect of resistance exercise on cardiovascular factors in the heart

To validate the observations mad using western blotting analysis and ELISA, we assessed the levels of the cardiovascular factors and inflammatory markers in the rats’ heart using immunohistochemistry. The thrombosis and atherosclerosis risk factor, PAI-1, was detectable in the hearts of the LETO and OLETF groups, but its intensity was significantly higher in the OLETF group when compared with OLETF + EX group (Fig. 3A and B). The endothelial markers, VCAM-1, ICAM-1, and E-selectin, were detected in the vicinity of cardiac vessels. Notably, the staining intensity was significantly higher in the OLETF group when compared with the OLETF + EX group (Fig. 3A and 3C–E). This analysis revealed that PAI-1, VACM-1, ICAM-1, and E-selectin were significantly decreased after exercise.Fig. 3 Immunohistochemical assay for cardiovascular factor. The cardiovascular factor was detected by DAB staining (A) and the quantification of the stained area (B–E). The scale bar indicated 40 μm. All experiments were repeated at least three times. *p < 0.05, **p < 0.01 compared to OLETF group.

Fig. 3

The cardiovascular inflammatory factor, CRP, was detected in the LETO and OLETF groups, but its intensity was significantly higher in the OLETF group when compared with the OLETF + EX group (Fig. 4A and C). The fibrotic factor, TGF-β, was markedly higher in the OLETF group when compared with the OLETF + EX group (Fig. 4A–B). Taken together, fibrotic and cardiovascular inflammatory factors were evaluated via immunohistochemical analysis of TGF-β and CRP expression. These findings suggest that exercise reduced the levels of diabetes-associated cardiovascular risk factors.Fig. 4 Immunohistochemical assay for fibrotic and cardiovascular inflammatory factor. The fibrotic and cardiovascular inflammatory factor was detected by DAB staining (A) and the quantification of the stained area (B and C). The scale bar indicated 40 μm **p < 0.01, ***p < 0.001 compared to OLETF group.

Fig. 4

3.5 The effect of resistance exercise on inflammatory markers in the heart

While the pro-inflammatory markers, TNF-α and IL-6, were detectable in the LETO and OLETF groups, their staining intensity was markedly higher in the OLETF group when compared with the OLETF + EX group (Fig. 5A–C). Moreover, the expression of the anti-inflammatory markers, IL-4 and IL-10, was significantly higher in the OLETF + EX group when compared with the OLETF group (Fig. 5A and 5D–E).Fig. 5 Immunohistochemical assay inflammatory factor. The inflammatory factor was detected by DAB staining (A) and the quantification of the stained area (B–E). The scale bar indicated 40 μm *p < 0.05, ***p < 0.001 compared to OLETF group.

Fig. 5

4 Discussion

In this study, diabetic rats underwent resistance training (three times/week and eight reps/session) to reduce inflammation and improve cardiovascular function. Our analysis revealed that resistance exercise gradually reduced the rats’ body weight and glucose levels. Moreover, it reduced the levels of the cardiovascular factors, PAI-1, VACM-1, ICAM-1, and E-selectin, the cardiovascular inflammatory marker, CRP, the fibrotic marker, TGF-β, and the pro-inflammatory markers, TNF-α and IL-6. Interestingly, western blotting analysis, ELISA, and immunohistochemistry revealed that the exercise group had increased levels of the anti-inflammatory markers, IL-4 and IL-10, rather than the non-exercise group. These results indicate that resistance exercise may help patients with diabetes more than other exercise and that these effects occur through the regulation of cardiovascular factors and inflammation.

The latest evidence shows that diabetes continues to be a large and increasing global health burden and is likely to continue to grow substantially through changing the lifestyle in the next decades [53]. The prevalence of T2DM is gradually increasing worldwide and is projected to reach 700 million cases by 2045 [54]. Without additional intervention, its mortality will continue to increase. The increasing diabetes prevalence is associated with obesity and fatty acid release, reduced insulin levels in muscles, and fat accumulation in liver, which disrupts glucose homeostasis [[55], [56], [57]]. Diabetes is characterized by symptoms of high blood glucose levels, including increased thirst and hunger, and frequent urination [58]. Diabetes is also associated with a 2–4-fold increase in the risk of myocardial ischemia-associated heart failure [59]. T2DM is the consequence of insufficient insulin secretion relative to insulin resistance with advanced age, excessive weight gain, and insufficient physical activity. Among genomic regions in T2DM, several genes are associated in regulation of insulin processing and secretion [[60], [61], [62], [63]].

To treat diabetes, many studies and clinicians have focused on maintaining healthy diet, daily medication, and regular physical exercise [58,64]. When diet and exercise fail to control weight loss and hyperglycemia, patients need antidiabetic agents, such as metformin, which is obtained from natural sources, such as herbs [65]. For drug treatment, the anti-diabetic drugs are mainly comprised of insulin, insulin analogs, and non-insulin hypoglycemic drugs [[66], [67], [68]]. Surgery is sometimes very effective in patients with both obesity and diabetes [58,69]. In addition, recent research showed that a bariatric surgery for treatment of T2DM in people with obesity led to superior glycemic control compared with medical or lifestyle intervention for a long-term management [70]. However, the side effect of bariatric surgery, such as chronic kidney disease, is important, so that the combination of medication and lifestyle is considered more effective and less consuming than surgical treatment [71].

Since the early 1900's, there has been interest in understanding the physiology of exercise in helping people with diabetes to regulate blood glucose and improve insulin sensitivity [72]. It was recognized in ancient times that physical exercise may be beneficial against diabetes [73]. The American Diabetes Association recommends that people with diabetes engage in aerobic activity for at least 150 min each week, and two to three sessions of resistance training exercise per week [74]. Aerobic training increases mitochondrial density, insulin sensitivity, oxidative enzyme levels, lung function, immune function, and cardiac output [75,76]. After exercise, insulin activity in the muscle and liver is enhanced, thereby improving glucose uptake. Resistance training reduced the glucose level in the blood of diabetes even though it was gradually increased in diabetes without exercise by time-dependent manner (Fig. 1).

In the clinic, aerobic exercise is beneficial for glycemic control and weight loss in patients with diabetes [77]. However, research on resistance training in patients with T2DM, both dry-bench and wet-bench, is limited. Although individual exercise studies in patients have shown partial results, exercise is expected to reduce the risk of diabetes [77]. In diabetic patients, before starting exercise sessions, must be carefully educated about the consequences of physical activity on their blood glucose and the appropriate modifications of diet and insulin therapy [78]. Long-term regular exercise is particularly advantageous for T2DM to reduce visceral fat mass and body weight without decreasing lean body mass [79]. In addition, regular aerobic exercise could ameliorate insulin sensitivity, glucose and blood pressure control, lipid profile and reduce the cardiovascular risk [80,81]. In our study, resistance exercise enhanced the level of cardiovascular factors in diabetes animal (Fig. 2, Fig. 3). In addition, the cardiovascular function could be recovered by reducing of fibrosis and cardiovascular inflammation (Fig. 4). The association between T2DM and heart failure remains inconclusive about reduced peripheral oxygen extraction, impaired heart rate adjustment, and lower anaerobic threshold, compared to non-diabetic subjects [82]. However, our results showed the potential of exercise through regulating of cardiovascular factors in diabetes patients, especially resistance exercise by occasionally. In addition, the understanding of cardiopulmonary response would allow the early identification at a higher risk of developing and help to understand the pathophysiological connection between T2DM and heart failure [82].

Lower level of inflammation contributes to the occurrence of metabolic syndrome. The markers of inflammation are pro-inflammatory cytokines/chemokines, such as IL-1β, IL-6, TNF-α, NF-κB, and interferon-γ [83,84]. Resistance training relates to a reduction in inflammatory markers in patients with T2DM, since those patients have reduced activation of anti-inflammatory pathway in a long-term period [85,86]. Inflammation is triggered by the innated immune system and act by surveillance of pathogens via recognition of receptors. The phenotypes of inflammation such as pro- and anti-inflammation have function differently following tissues including muscles, adipose tissues, vessels or etc. Exercise-induced effects on inflammation have additional complexity by specific pro-inflammatory cytokines. Early sport science studies revealed an increase in IL-6 by prolonged endurance exercise. After then, it was resulted of muscle damage and subsequent inflammation. Resistance exercise reduced the pro-inflammation and enhanced the anti-inflammation (Fig. 5). The time-course of resistance training-induced adaptations on the endothelium is still not clear, even though vascular alterations may occur from the first week of exercise and be overcome by later adaptations [87].

In recent years, diabetes treatments, which not only lower blood glucose levels but decrease cardiovascular dysfunction, have been shown to reduce major cardiovascular events [88]. However, those cellular mechanisms are not fully explaining the key factors in diabetes treatment. An in-depth understanding of the signaling pathways and mechanisms involved in exercise's benefits for cardiovascular health will guide the development of novel therapeutic targets and strategies in the future [89]. Several studies already confirmed that the aerobic exercise could improve the cardiovascular function. The most important factor is resistance exercise, which has beneficial effects, such as enhancing cardiovascular factors and reducing inflammation. Therefore, we suggest a continuous resistance training program for people with diabetes.

Resistance exercise that requires lower cardiorespiratory fitness than aerobic exercise has a beneficial effect on metabolic disease patients who are not able to perform aerobic exercises for a long time. Although we suggested the positive potential of exercise, the limitations of our work still remain. Firstly, we investigated the effect of the resistance training not an aerobic exercise in the in vivo diabetes model. Second, most of T2DM patients are old-aged, however, we did not consider to make a training program for the aged person. Third, recent studies identified the exercise-regulated molecules as potential biomarkers for guiding a more effective and safe exercise training for patients; however, we did not check the effect of them yet. Therefore, to find a regulator of diabetes and to apply the suitable training for subject is our next goal for T2DM therapy, such as miRNAs. Despite the rapid and cost-effective development, the gene therapy needs further exploration of lower immunogenicity.

5 Conclusions

We revealed that the resistance exercise gradually reduced the body weight and glucose level in the diabetic rats. Moreover, exercise has a potential effect to reduce the inflammation and induce the cardiovascular function. Following the results, the resistance training for people with diabetes might be a key factor to rescue the disease.

Data availability statement

All data generated or analyzed during this study are included in this published article and supplementary information.

CRediT authorship contribution statement

Jin Yoo: Investigation, Funding acquisition, Data curation, Conceptualization. Jinsu Hwang: Software, Formal analysis, Data curation. Jiyun Choi: Formal analysis, Data curation. Mahesh Ramalingam: Validation, Software, Formal analysis, Data curation. Haewon Jeong: Formal analysis, Data curation. Sujeong Jang: Supervision, Software, Investigation, Funding acquisition, Formal analysis, Data curation, Conceptualization. Han-Seong Jeong: Supervision, Project administration, Investigation, Funding acquisition. Daeyeol Kim: Supervision, Project administration, Investigation, Funding acquisition, Conceptualization.

Declaration of competing interest

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Sujeong Jang, Han-Seong Jeong, Jin Yoo reports equipment, drugs, or supplies was provided by National Research Foundation of Korea. Han-Seong Jeong reports article publishing charges and equipment, drugs, or supplies were provided by Korea Institute for Advancement of Technology. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Appendix A Supplementary data

The following is the Supplementary data to this article:Multimedia component 1

Multimedia component 1

Acknowledgements

This research was supported by grants from the 10.13039/501100003725 National Research Foundation of Korea (grant numbers NRF-2023S1A5BA19094510 , NRF-2021R1I1A3060435 , and NRF-2020R1F1A1076616 ), Republic of Korea; a grant from the 10.13039/501100003661 Korea Institute for Advancement of Technology (KIAT, grant number P0020818 ) funded by the Korean Government (MOTIE), Republic of Korea.

Appendix A Supplementary data to this article can be found online at https://doi.org/10.1016/j.heliyon.2024.e37081.
==== Refs
References

1 Galtier F. Definition, epidemiology, risk factors Diabetes Metab. 36 6 Pt 2 2010 628 651 21163426
2 American Diabetes A. Diagnosis and classification of diabetes mellitus Diabetes Care 37 Suppl 1 2014 S81 S90 24357215
3 Kharroubi A.T. Darwish H.M. Diabetes mellitus: the epidemic of the century World J. Diabetes 6 6 2015 850 867 26131326
4 Qaid M.M. Abdelrahman M.M. Role of insulin and other related hormones in energy metabolism—a review Cogent Food Agric. 2 1 2016 1267691
5 Kakleas K. Soldatou A. Karachaliou F. Karavanaki K. Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus (T1DM) Autoimmun. Rev. 14 9 2015 781 797 26001590
6 Katsarou A. Gudbjornsdottir S. Rawshani A. Dabelea D. Bonifacio E. Anderson B.J. Jacobsen L.M. Schatz D.A. Lernmark A. Type 1 diabetes mellitus Nat. Rev. Dis. Prim. 3 2017 17016
7 Paschou S.A. Papadopoulou-Marketou N. Chrousos G.P. Kanaka-Gantenbein C. On type 1 diabetes mellitus pathogenesis Endocr Connect 7 1 2018 R38 R46 29191919
8 Ilonen J. Lempainen J. Veijola R. The heterogeneous pathogenesis of type 1 diabetes mellitus Nat. Rev. Endocrinol. 15 11 2019 635 650 31534209
9 Akash M.S. Rehman K. Chen S. Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus J. Cell. Biochem. 114 3 2013 525 531 22991242
10 Chao M.L. Luo S. Zhang C. Zhou X. Zhou M. Wang J. Kong C. Chen J. Lin Z. Tang X. Sun S. Tang X. Chen H. Wang H. Wang D. Sun J.P. Han Y. Xie L. Ji Y. S-nitrosylation-mediated coupling of G-protein alpha-2 with CXCR5 induces Hippo/YAP-dependent diabetes-accelerated atherosclerosis Nat Commun 12 1 2021 4452 34294713
11 Einarson T.R. Acs A. Ludwig C. Panton U.H. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017 Cardiovasc. Diabetol. 17 1 2018 83 29884191
12 Emerging Risk Factors C. Sarwar N. Gao P. Seshasai S.R. Gobin R. Kaptoge S. Di Angelantonio E. Ingelsson E. Lawlor D.A. Selvin E. Stampfer M. Stehouwer C.D. Lewington S. Pennells L. Thompson A. Sattar N. White I.R. Ray K.K. Danesh J. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies Lancet 375 9733 2010 2215 2222 20609967
13 Martin-Timon I. Sevillano-Collantes C. Segura-Galindo A. Del Canizo-Gomez F.J. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength? World J. Diabetes 5 4 2014 444 470 25126392
14 Akash M.S.H. Rehman K. Liaqat A. Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus J. Cell. Biochem. 119 1 2018 105 110 28569437
15 Rihawi K. Ricci A.D. Rizzo A. Brocchi S. Marasco G. Pastore L.V. Llimpe F.L.R. Golfieri R. Renzulli M. Tumor-associated macrophages and inflammatory microenvironment in gastric cancer: novel translational implications Int. J. Mol. Sci. 22 8 2021
16 Vitale E. Rizzo A. Santa K. Jirillo E. Associations between "cancer risk", "inflammation" and "metabolic syndrome": a scoping review Biology 13 5 2024
17 Indio V. Schipani A. Nannini M. Urbini M. Rizzo A. De Leo A. Altimari A. Di Scioscio V. Messelodi D. Tarantino G. Astolfi A. Pantaleo M.A. Gene expression landscape of SDH-deficient gastrointestinal stromal tumors J. Clin. Med. 10 5 2021
18 Rizzo A. Santoni M. Mollica V. Fiorentino M. Brandi G. Massari F. Microbiota and prostate cancer Semin. Cancer Biol. 86 Pt 3 2022 1058 1065 34536504
19 Di Federico A. Mosca M. Pagani R. Carloni R. Frega G. De Giglio A. Rizzo A. Ricci D. Tavolari S. Di Marco M. Palloni A. Brandi G. Immunotherapy in pancreatic cancer: why do we keep failing? A focus on tumor immune microenvironment, predictive biomarkers and treatment outcomes Cancers 14 10 2022
20 Vaughan D.E. PAI-1 and atherothrombosis J Thromb Haemost 3 8 2005 1879 1883 16102055
21 Ploplis V.A. Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease Curr. Drug Targets 12 12 2011 1782 1789 21707474
22 Ghosh A.K. Vaughan D.E. PAI-1 in tissue fibrosis J. Cell. Physiol. 227 2 2012 493 507 21465481
23 Baluta M.M. Vintila M.M. PAI-1 inhibition - another therapeutic option for cardiovascular protection Maedica (Bucur) 10 2 2015 147 152 28275409
24 Schneider D.J. Sobel B.E. PAI-1 and diabetes: a journey from the bench to the bedside Diabetes Care 35 10 2012 1961 1967 22996180
25 Van De Craen B. Declerck P.J. Gils A. The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo Thromb. Res. 130 4 2012 576 585 22801256
26 Martins S.R. Toledo S.L.O. da Silva A.J. Mendes F.S. de Oliveira M.M. Ferreira L.G.R. Dusse L.M.S. Carvalho M.D.G. Rios D.R.A. Alpoim P.N. Pinheiro M.B. Endothelial dysfunction biomarkers in sickle cell disease: is there a role for ADMA and PAI-1? Ann. Hematol. 101 2 2022 273 280 34665295
27 Gupta S.K. Dongare S. Mathur R. Mohanty I.R. Srivastava S. Mathur S. Nag T.C. Genistein ameliorates cardiac inflammation and oxidative stress in streptozotocin-induced diabetic cardiomyopathy in rats Mol. Cell. Biochem. 408 1–2 2015 63 72 26092427
28 Knudsen S.H. Pedersen B.K. Targeting inflammation through a physical active lifestyle and pharmaceuticals for the treatment of type 2 diabetes Curr Diab Rep 15 10 2015 82 26358738
29 Karstoft K. Pedersen B.K. Exercise and type 2 diabetes: focus on metabolism and inflammation Immunol. Cell Biol. 94 2 2016 146 150 26568029
30 Liu C. Feng X. Li Q. Wang Y. Li Q. Hua M. Adiponectin, TNF-alpha and inflammatory cytokines and risk of type 2 diabetes: a systematic review and meta-analysis Cytokine 86 2016 100 109 27498215
31 Lee J. Lee S. Zhang H. Hill M.A. Zhang C. Park Y. Interaction of IL-6 and TNF-alpha contributes to endothelial dysfunction in type 2 diabetic mouse hearts PLoS One 12 11 2017 e0187189
32 Zanuso S. Balducci S. Jimenez A. Physical activity, a key factor to quality of life in type 2 diabetic patients Diabetes Metab Res Rev 25 Suppl 1 2009 S24 S28 19662618
33 Balducci S. Sacchetti M. Haxhi J. Orlando G. D'Errico V. Fallucca S. Menini S. Pugliese G. Physical exercise as therapy for type 2 diabetes mellitus Diabetes Metab Res Rev 30 Suppl 1 2014 13 23 24353273
34 Mann S. Beedie C. Balducci S. Zanuso S. Allgrove J. Bertiato F. Jimenez A. Changes in insulin sensitivity in response to different modalities of exercise: a review of the evidence Diabetes Metab Res Rev 30 4 2014 257 268 24130081
35 Pesta D.H. Goncalves R.L.S. Madiraju A.K. Strasser B. Sparks L.M. Resistance training to improve type 2 diabetes: working toward a prescription for the future Nutr. Metab. 14 2017 24
36 Sabouri M. Hatami E. Pournemati P. Shabkhiz F. Inflammatory, antioxidant and glycemic status to different mode of high-intensity training in type 2 diabetes mellitus Mol. Biol. Rep. 48 6 2021 5291 5304 34228273
37 Jayedi A. Emadi A. Shab-Bidar S. Dose-dependent effect of supervised aerobic exercise on HbA(1c) in patients with type 2 diabetes: a meta-analysis of randomized controlled trials Sports Med. 52 8 2022 1919 1938 35362859
38 Eves N.D. Plotnikoff R.C. Resistance training and type 2 diabetes: considerations for implementation at the population level Diabetes Care 29 8 2006 1933 1941 16873809
39 Ciccolo J.T. Carr L.J. Krupel K.L. Longval J.L. The role of resistance training in the prevention and treatment of chronic disease Am. J. Lifestyle Med. 4 4 2010 293 308
40 Hall K.E. McDonald M.W. Grise K.N. Campos O.A. Noble E.G. Melling C.W. The role of resistance and aerobic exercise training on insulin sensitivity measures in STZ-induced Type 1 diabetic rodents Metabolism 62 10 2013 1485 1494 23810201
41 Flack K.D. Davy K.P. Hulver M.W. Winett R.A. Frisard M.I. Davy B.M. Aging, resistance training, and diabetes prevention J Aging Res 2011 2010 127315
42 Westcott W.L. Resistance training is medicine: effects of strength training on health Curr. Sports Med. Rep. 11 4 2012 209 216 22777332
43 Abd El-Kader S.M. Aerobic versus resistance exercise training in modulation of insulin resistance, adipocytokines and inflammatory cytokine levels in obese type 2 diabetic patients J. Adv. Res. 2 2 2011 179 183
44 Calle M.C. Fernandez M.L. Effects of resistance training on the inflammatory response Nutr Res Pract 4 4 2010 259 269 20827340
45 Hemanthakumar K.A. Fang S. Anisimov A. Mayranpaa M.I. Mervaala E. Kivela R. Cardiovascular disease risk factors induce mesenchymal features and senescence in mouse cardiac endothelial cells Elife 10 2021
46 Kwon H.R. Min K.W. Ahn H.J. Seok H.G. Lee J.H. Park G.S. Han K.A. Effects of aerobic exercise vs. Resistance training on endothelial function in women with type 2 diabetes mellitus Diabetes Metab. J 35 4 2011 364 373 21977456
47 Shimomura M. Horii N. Fujie S. Inoue K. Hasegawa N. Iemitsu K. Uchida M. Iemitsu M. Decreased muscle-derived musclin by chronic resistance exercise is associated with improved insulin resistance in rats with type 2 diabetes Physiol Rep 9 9 2021 e14823
48 Dinger K. Mohr J. Vohlen C. Hirani D. Hucklenbruch-Rother E. Ensenauer R. Dotsch J. Alejandre Alcazar M.A. Intraperitoneal glucose tolerance test, measurement of lung function, and fixation of the lung to study the impact of obesity and impaired metabolism on pulmonary outcomes J. Vis. Exp. 133 2018
49 Soni K.K. Hwang J. Ramalingam M. Kim C. Kim B.C. Jeong H.S. Jang S. Endoplasmic reticulum stress causing apoptosis in a mouse model of an ischemic spinal cord injury Int. J. Mol. Sci. 24 2 2023
50 Ramalingam M. Jang S. Jeong H.S. Therapeutic effects of conditioned medium of neural differentiated human bone marrow-derived stem cells on rotenone-induced alpha-synuclein aggregation and apoptosis Stem Cells Int 2021 2021 6658271
51 Karamese M. Aydin H. Sengul E. Gelen V. Sevim C. Ustek D. Karakus E. The immunostimulatory effect of lactic acid bacteria in a rat model Iran J Immunol 13 3 2016 220 228 27671513
52 Jang S. Cho H.H. Kim S.H. Lee K.H. Cho Y.B. Park J.S. Jeong H.S. Transplantation of human adipose tissue-derived stem cells for repair of injured spiral ganglion neurons in deaf Guinea pigs Neural Regen Res 11 6 2016 994 1000 27482231
53 Guariguata L. Whiting D.R. Hambleton I. Beagley J. Linnenkamp U. Shaw J.E. Global estimates of diabetes prevalence for 2013 and projections for 2035 Diabetes Res. Clin. Pract. 103 2 2014 137 149 24630390
54 Magkos F. Hjorth M.F. Astrup A. Diet and exercise in the prevention and treatment of type 2 diabetes mellitus Nat. Rev. Endocrinol. 16 10 2020 545 555 32690918
55 Mittendorfer B. Magkos F. Fabbrini E. Mohammed B.S. Klein S. Relationship between body fat mass and free fatty acid kinetics in men and women Obesity 17 10 2009 1872 1877 19629053
56 Conte C. Fabbrini E. Kars M. Mittendorfer B. Patterson B.W. Klein S. Multiorgan insulin sensitivity in lean and obese subjects Diabetes Care 35 6 2012 1316 1321 22474039
57 Wilman H.R. Kelly M. Garratt S. Matthews P.M. Milanesi M. Herlihy A. Gyngell M. Neubauer S. Bell J.D. Banerjee R. Thomas E.L. Characterisation of liver fat in the UK Biobank cohort PLoS One 12 2 2017 e0172921
58 Bailey C. Skouteris H. Teede H. Hill B. De Courten B. Walker R. Liew D. Thangaratinam S. Ademi Z. Are lifestyle interventions to reduce excessive gestational weight gain cost effective? A systematic review Curr Diab Rep 20 2 2020 6 32008111
59 Park J.J. Epidemiology, pathophysiology, diagnosis and treatment of heart failure in diabetes Diabetes Metab. J 45 2 2021 146 157 33813813
60 Dimas A.S. Lagou V. Barker A. Knowles J.W. Magi R. Hivert M.F. Benazzo A. Rybin D. Jackson A.U. Stringham H.M. Song C. Fischer-Rosinsky A. Boesgaard T.W. Grarup N. Abbasi F.A. Assimes T.L. Hao K. Yang X. Lecoeur C. Barroso I. Bonnycastle L.L. Bottcher Y. Bumpstead S. Chines P.S. Erdos M.R. Graessler J. Kovacs P. Morken M.A. Narisu N. Payne F. Stancakova A. Swift A.J. Tonjes A. Bornstein S.R. Cauchi S. Froguel P. Meyre D. Schwarz P.E. Haring H.U. Smith U. Boehnke M. Bergman R.N. Collins F.S. Mohlke K.L. Tuomilehto J. Quertemous T. Lind L. Hansen T. Pedersen O. Walker M. Pfeiffer A.F. Spranger J. Stumvoll M. Meigs J.B. Wareham N.J. Kuusisto J. Laakso M. Langenberg C. Dupuis J. Watanabe R.M. Florez J.C. Ingelsson E. McCarthy M.I. Prokopenko I. Investigators M. Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity Diabetes 63 6 2014 2158 2171 24296717
61 McCarthy M.I. Genomics, type 2 diabetes, and obesity N. Engl. J. Med. 363 24 2010 2339 2350 21142536
62 Kretowski A. Ruperez F.J. Ciborowski M. Genomics and metabolomics in obesity and type 2 diabetes J. Diabetes Res. 2016 2016 9415645
63 Diedisheim M. Carcarino E. Vandiedonck C. Roussel R. Gautier J.F. Venteclef N. Regulation of inflammation in diabetes: from genetics to epigenomics evidence Mol Metab 41 2020 101041
64 Simos Y.V. Spyrou K. Patila M. Karouta N. Stamatis H. Gournis D. Dounousi E. Peschos D. Trends of nanotechnology in type 2 diabetes mellitus treatment Asian J. Pharm. Sci. 16 1 2021 62 76 33613730
65 Abu-Odeh A.M. Talib W.H. Middle East medicinal plants in the treatment of diabetes: a review Molecules 26 3 2021
66 Moroder L. Musiol H.J. Insulin-from its discovery to the industrial synthesis of modern insulin analogues Angew Chem. Int. Ed. Engl. 56 36 2017 10656 10669 28548452
67 El Naggar N. Kalra S. Switching from biphasic human insulin to premix insulin analogs: a review of the evidence regarding quality of life and adherence to medication in type 2 diabetes mellitus Adv. Ther. 33 12 2017 2091 2109 27739002
68 Zhao R. Lu Z. Yang J. Zhang L. Li Y. Zhang X. Drug delivery system in the treatment of diabetes mellitus Front. Bioeng. Biotechnol. 8 2020 880 32850735
69 Cash J.C. Family Practice Guidelines 2023 Springer Publishing Company
70 Courcoulas A.P. Patti M.E. Hu B. Arterburn D.E. Simonson D.C. Gourash W.F. Jakicic J.M. Vernon A.H. Beck G.J. Schauer P.R. Kashyap S.R. Aminian A. Cummings D.E. Kirwan J.P. Long-term outcomes of medical management vs bariatric surgery in type 2 diabetes JAMA 331 8 2024 654 664 38411644
71 Mingrone G. Panunzi S. De Gaetano A. Guidone C. Iaconelli A. Capristo E. Chamseddine G. Bornstein S.R. Rubino F. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial Lancet 397 10271 2021 293 304 33485454
72 Rev VJTAt 3rd Ed. 1938 Nirnyar Sagar Press Bombay
73 Horton E.S. Role and management of exercise in diabetes mellitus Diabetes Care 11 2 1988 201 211 3289869
74 Zahalka S.J. Abushamat L.A. Scalzo R.L. Reusch J.E.B. Feingold K.R. Anawalt B. Blackman M.R. Boyce A. Chrousos G. Corpas E. de Herder W.W. Dhatariya K. Dungan K. Hofland J. Kalra S. Kaltsas G. Kapoor N. Koch C. Kopp P. Korbonits M. Kovacs C.S. Kuohung W. Laferrere B. Levy M. McGee E.A. McLachlan R. New M. Purnell J. Sahay R. Shah A.S. Singer F. Sperling M.A. Stratakis C.A. Trence D.L. Wilson D.P. The Role of Exercise in Diabetes 2000 Endotext South Dartmouth (MA)
75 Colberg S.R. Sigal R.J. Yardley J.E. Riddell M.C. Dunstan D.W. Dempsey P.C. Horton E.S. Castorino K. Tate D.F. Physical activity/exercise and diabetes: a position statement of the American diabetes association Diabetes Care 39 11 2016 2065 2079 27926890
76 Garber C.E. Blissmer B. Deschenes M.R. Franklin B.A. Lamonte M.J. Lee I.M. Nieman D.C. Swain D.P. American College of Sports M. American College of Sports Medicine position stand Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise Med. Sci. Sports Exerc. 43 7 2011 1334 1359 21694556
77 Boule N.G. Haddad E. Kenny G.P. Wells G.A. Sigal R.J. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials JAMA 286 10 2001 1218 1227 11559268
78 Improta-Caria A.C. De Sousa R.A.L. Roever L. Fernandes T. Oliveira E.M. Aras Junior R. Souza B.S.F. MicroRNAs in type 2 diabetes mellitus: potential role of physical exercise Rev. Cardiovasc. Med. 23 1 2022 29 35092221
79 Amanat S. Ghahri S. Dianatinasab A. Fararouei M. Dianatinasab M. Exercise and type 2 diabetes Adv. Exp. Med. Biol. 1228 2020 91 105 32342452
80 De Feo P. Di Loreto C. Ranchelli A. Fatone C. Gambelunghe G. Lucidi P. Santeusanio F. Exercise and diabetes Acta Biomed. 77 Suppl 1 2006 14 17
81 Viggers R. Al-Mashhadi Z. Fuglsang-Nielsen R. Gregersen S. Starup-Linde J. The impact of exercise on bone health in type 2 diabetes mellitus-a systematic review Curr. Osteoporos. Rep. 18 4 2020 357 370 32529455
82 Nesti L. Pugliese N.R. Sciuto P. Natali A. Type 2 diabetes and reduced exercise tolerance: a review of the literature through an integrated physiology approach Cardiovasc. Diabetol. 19 1 2020 134 32891175
83 Guillemot-Legris O. Muccioli G.G. Obesity-induced neuroinflammation: beyond the hypothalamus Trends Neurosci. 40 4 2017 237 253 28318543
84 Roh H.T. Cho S.Y. So W.Y. A cross-sectional study evaluating the effects of resistance exercise on inflammation and neurotrophic factors in elderly women with obesity J. Clin. Med. 9 3 2020
85 Hopps E. Canino B. Caimi G. Effects of exercise on inflammation markers in type 2 diabetic subjects Acta Diabetol. 48 3 2011 183 189 21431832
86 Rech A. Botton C.E. Lopez P. Quincozes-Santos A. Umpierre D. Pinto R.S. Effects of short-term resistance training on endothelial function and inflammation markers in elderly patients with type 2 diabetes: a randomized controlled trial Exp. Gerontol. 118 2019 19 25 30611727
87 Tinken T.M. Thijssen D.H. Hopkins N. Dawson E.A. Cable N.T. Green D.J. Shear stress mediates endothelial adaptations to exercise training in humans Hypertension 55 2 2010 312 318 20048193
88 Suryasa I.W. Rodríguez-Gámez M. Koldoris T. Health and treatment of diabetes mellitus Int. J. Health Sci. 5 1 2021
89 Chen H. Chen C. Spanos M. Li G. Lu R. Bei Y. Xiao J. Exercise training maintains cardiovascular health: signaling pathways involved and potential therapeutics Signal Transduct Target Ther 7 1 2022 306 36050310
